KRISTEN HEIDEGER: Open Payments
NPI 1497395529 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 41 payments from 9 companies in 2025. Trend: 2023 $198 · 2024 $71 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $438 |
| SANOFI-AVENTIS U.S. LLC | 3 | $57 |
| Amgen Inc. | 3 | $55 |
| Lundbeck LLC | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| SCILEX PHARMACEUTICALS INC. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: Wegovy, Ozempic, TZIELD, OTEZLA, Rybelsus, REXULTI, FARXIGA, Kerendia.
Industry payments across AL — which companies pay providers there.
